Your browser doesn't support javascript.
loading
Gender-specific survival after surgical resection for early stage non-small cell lung cancer.
Bugge, Anders; Kongerud, Johny; Brunborg, Cathrine; Solberg, Steinar; Lund, May Brit.
  • Bugge A; a Department of Cardiothoracic Surgery, Division of Cardiovascular and Pulmonary Diseases , Oslo University Hospital , Rikshospitalet , Norway.
  • Kongerud J; b Faculty of Medicine , University of Oslo , Norway.
  • Brunborg C; b Faculty of Medicine , University of Oslo , Norway.
  • Solberg S; c Department of Respiratory Medicine, Division of Cardiovascular and Pulmonary Diseases , Oslo University Hospital , Rikshospitalet , Norway.
  • Lund MB; d Oslo Centre for Biostatistics and Epidemiology , Research Support Services, Oslo University Hospital , Norway.
Acta Oncol ; 56(3): 448-454, 2017 Mar.
Article en En | MEDLINE | ID: mdl-27846762
ABSTRACT

BACKGROUND:

Lung cancer is the leading cause of cancer death worldwide. The incidence and mortality rate of lung cancer in women has increased. Studies have indicated that females with non-small cell lung cancer (NSCLC) have better survival than males. We aimed to examine the impact of gender on 1-, 5- and 10-year survival after surgery for stage I and II NSCLC. MATERIALS AND

METHODS:

During the period 2003-2013, 692 patients operated for stage I and II NSCLC were prospectively registered. Patients were stratified into four groups according to gender and age over or less than 66 years. The relationship between gender and age on overall survival was investigated. Adjustment for multiple confounders was performed using the Cox proportional hazard regression model.

RESULTS:

Surgical resection was performed in 368 (53.2%) males and 324 (46.8%) females. During the study period, mortality was 35.2% in younger females, 34.9% in younger males, 42.8% in older females and 51.2% in older males. Stratified by age, there were no significant gender differences with regard to survival [hazard ratio (HR) 1.16, 95% confidence interval (CI) 0.91-1.46, p = .23]. Comparing the younger and the older patients adjusted for confounders, the mortality risk was significantly increased in elderly patients [females, adjusted HR 1.60, 95% CI 1.12-2.28]. Compared with population data, standardized mortality ratio was increased to 4.1 (95% CI 3.5-4.7) in males and to 6.5 (95% CI 5.4-7.6) in females.

CONCLUSION:

Overall survival did not differ significantly between males and females. Adjusted for confounding factors, we found a significantly increased mortality risk in elder patients compared to their younger counterparts. However, five-year overall survival of more than 50% for older patients with NSCLC should encourage surgical treatment also in elderly lung cancer patients.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article